EICHOR
● Completed
Evaluation of the Efficacy and Safety of Nal-IRI for Progressing Brain Metastases in Breast Cancer Patients
Condition: Breast Cancer Metastatic · Sponsor: MedSIR
About this study
Multicenter open-label, phase II trial, to evaluate the efficacy and safety of nal-IRI in patients with HER2-negative breast cancer, who have documented Central Nervous System (CNS) progression following Whole Brain Radio Therapy (WBRT), Stereotactic Radiosurgery (SRS) and/or surgery, as determined by the Response Assessment in Neuro-Oncology Brain Metastases (RANO-BM) criteria.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (16)
| ICO | Badalona, Spain | — |
| IOB Institute of Oncology - Quirón Barcelona | Barcelona, Spain | — |
| Hospital Universitario Virgen de Las Nieves | Granada, Spain | — |
| Hospital Universitario Clinico San Cecilio | Granada, Spain | — |
| H. Ruber Juan Bravo | Madrid, Spain | — |
| Hospital Clínico San Carlos | Madrid, Spain | — |
| Hospital Doce de Octubre | Madrid, Spain | — |
| Hospital Universitario Ramón y Cajal | Madrid, Spain | — |
| MD Anderson Madrid | Madrid, Spain | — |
| Hospital Clínico Virgen de la Victoria | Málaga, Spain | — |
| Hospital Universitari Son Espases | Palma de Mallorca, Spain | — |
| Son Llatzer | Palma de Mallorca, Spain | — |
+ 4 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03328884